Erratum: Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease (PLoS ONE (2014) 9:10 (e109772) DOI: 10.1371/journal.pone.0109772));Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Fízei'ová, Mária ^a   Cederberg, Henna ^b   Stančáková, Alena ^a   Jauhiainen, Raimo ^b   Vangipurapu, Jagadish ^a   Kuusisto, Johanna ^b   Laakso, Markku ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADIPOCYTE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE EXACERBATION; DISEASE MARKER; FINN (CITIZEN); FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; SKELETAL MUSCLE; TISSUE SPECIFICITY; ANTIBODY SPECIFICITY; BLOOD; COMPLICATION; DIET RESTRICTION; FINLAND; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FASTING; FINLAND; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; ORGAN SPECIFICITY;

EID: 84907919515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114705     Document Type: Erratum

References (32)

1. Defronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
2. Tripathy D, Almgren P, Tuomi T, Groop L (2004) Contribution of insulinstimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 27: 2204-2210.
3. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulindependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992.
4. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94.
5. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, et al. (1991) Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11: 1068-1076.
6. Bressler P, Bailey SR, Matsuda M, DeFronzo RA (1996) Insulin resistance and coronary artery disease. Diabetologia 39: 1345-1350.
7. Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, et al. (2013) Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62: 1730-1737.
8. Lorenzo C, Wagenknecht LE, D'Agostino RB Jr., Rewers MJ, Karter AJ, et al. (2010) Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: The Insulin Resistance Atherosclerosis Study. Diabetes Care 33: 67-72.
9. Walker M, Mari A, Jayapaul MK, Bennett SM, Ferrannini E (2005) Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia 48: 2470-2476.
10. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, et al. (2005) Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54: 166-174.
11. DeFronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America 88: 787-835.
12. Zierath JR, Kawano Y (2003) The effect of hyperglycaemia on glucose disposal and insulin signal transduction in skeletal muscle. Best Practice & Research Clinical Endocrinology & Metabolism 17: 385-398.
13. Cherrington AD (1999) Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48: 1198-1214.
14. Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. 25: 1289-1294.
15. Gastaldelli A, Natali A, Vettor R, Corradini SG (2010) Insulin resistance, adipose depots and gut: interactions and pathological implications. Dig Liver Dis 42: 310-319.
16. Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959-965.
17. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM (2012) Insulin resistance and risk of incident cardiovascular events in adults without diabetes: Meta-analysis. PLoS One 7: e52036.
18. Kuusisto J, Lempiainen P, Mykkanen L, Laakso M (2001) Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care 24: 1629-1633.
19. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
20. Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667-E677.
21. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, et al. (2000) Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care 23: 1440-1441.
22. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410.
23. Stancakova A, Javorsky M, Kuulasmaa T, Haffner SM, Kuusisto J, et al. (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6, 414 Finnish men. Diabetes 58: 1212-1221.
24. Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, Defronzo RA (2008) Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 45: 147-150.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412- 419.
26. Vangipurapu J, Stancakova A, Kuulasmaa T, Paananen J, Kuusisto J, et al. (2011) A novel surrogate index for hepatic insulin resistance. Diabetologia 54: 540-543.
27. American Diabetes A (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl 1: S43-S48.
28. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, et al. (2012) Third universal definition of myocardial infarction. Eur Heart J 33: 2551-2567.
29. European Stroke Initiative Executive C, Committee EW, Olsen TS, Langhorne P, Diener HC, et al. (2003) European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis 16: 311-337.
30. Defronzo RA, Simonson D, Ferrannini E (1982) Hepatic and Peripheral Insulin Resistance - A Common Feature of Non-Insulin-Dependent (Nidd) and Insulin- Dependent Diabetes (Idd). Clinical Research 30: A523-A523.
31. Lorenzo C, Haffner SM, Stancakova A, Laakso M (2010) Relation of Direct and Surrogate Measures of Insulin Resistance to Cardiovascular Risk Factors in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals. Journal of Clinical Endocrinology & Metabolism 95: 5082-5090.
32. Groop LC, Bonadonna RC, Delprato S, Ratheiser K, Zyck K, et al. (1989) Glucose and Free Fatty-Acid Metabolism in Non-Insulin-Dependent Diabetes- Mellitus - Evidence for Multiple Sites of Insulin Resistance Journal of Clinical Investigation 84: 205-213.